Transgene SA (EPA:TNG)
0.7140
+0.0030 (0.42%)
Aug 3, 2026, 2:20 PM CET
Transgene Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 6.66 | 16.67 | 15.67 | 4.4 | 5.91 |
Short-Term Investments | 105.2 | - | - | 22.42 | 43.66 |
Cash & Short-Term Investments | 111.86 | 16.67 | 15.67 | 26.83 | 49.57 |
Cash Growth | 571.01% | 6.41% | -41.60% | -45.88% | 88.09% |
Accounts Receivable | 3.65 | 1.19 | 0.78 | 2.79 | 10.13 |
Other Current Assets | 2.17 | 2.81 | 1.54 | 16.89 | 2.54 |
Total Current Assets | 117.68 | 20.67 | 17.98 | 46.51 | 62.25 |
Net Property, Plant & Equipment | 13.5 | 14.29 | 12.31 | 11.18 | 11.3 |
Other Intangible Assets | 0.05 | 0.06 | 0.08 | 0.08 | 0.09 |
Long-Term Investments | 0.83 | 0.93 | 1.35 | 1.67 | 20.77 |
Other Long-Term Assets | 6.77 | 6.22 | 13.49 | 7 | 7.43 |
Total Assets | 138.83 | 42.17 | 45.22 | 66.44 | 101.84 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 6.02 | 9.5 | 4.55 | 6.97 | 7.69 |
Short-Term Debt | 0.4 | 0.18 | 1.33 | 1.19 | 1.4 |
Other Current Liabilities | 5.81 | 4.3 | 4.17 | 4.63 | 5.5 |
Total Current Liabilities | 12.23 | 13.98 | 10.04 | 12.78 | 14.59 |
Long-Term Debt | 1.66 | 10.22 | 15.96 | 12.33 | 15.24 |
Other Long-Term Liabilities | 3.2 | 2.77 | 3.6 | 3.49 | 4.8 |
Total Long-Term Liabilities | 4.86 | 12.99 | 19.56 | 15.81 | 20.04 |
Total Liabilities | 17.09 | 26.97 | 29.61 | 28.6 | 34.63 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 82.26 | 66.15 | 50.43 | 50.1 | 48.89 |
Additional Paid-in Capital | 116.67 | 89.23 | 71.59 | 71.62 | 70.37 |
Accumulated Other Comprehensive Income | -0.68 | -0.45 | -0.64 | -0.45 | -1.42 |
Retained Earnings | -76.51 | -139.73 | -105.76 | -83.43 | -50.63 |
Shareholders' Equity | 121.74 | 15.2 | 15.61 | 37.84 | 67.21 |
Total Liabilities & Equity | 138.83 | 42.17 | 45.22 | 66.44 | 101.84 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2.06 | 10.4 | 17.3 | 13.52 | 16.64 |
Net Cash (Debt) | 109.8 | 6.27 | -1.63 | 13.31 | 32.93 |
Net Cash Growth | 1650.06% | - | - | -59.59% | 312.18% |
Net Cash Per Share | 0.76 | 0.05 | -0.02 | 0.13 | 0.36 |
Book Value | 121.74 | 15.2 | 15.61 | 37.84 | 67.21 |
Book Value Per Share | 0.84 | 0.13 | 0.16 | 0.38 | 0.74 |
Tangible Book Value | 121.69 | 15.14 | 15.53 | 37.76 | 67.12 |
Tangible Book Value Per Share | 0.84 | 0.13 | 0.15 | 0.38 | 0.74 |